The Potential of Gene Editing in Treating Genetic Disorders
Rejith P R, Correspondent, India Pharma Outlook
FDA has recently approved two groundbreaking treatments, Casgevy and Lyfgenia, which characterize the cell-based gene therapies for treating sickle cell diseases in individuals 12 years and older. Casegevy was the first approved treatment to use...